Rettinger J , Schmalzing G .

	Figure 1. . Schematic drawing of the fast solution exchange device. (A) Cross-section (top) and top view (bottom) of the perfusion chamber. The oocyte is placed in a small cavity possessing an internal volume of 10 μl and superfused at a constant flow rate of ≈200 μl/s through a glass-capillary of 1.2-mm internal diameter connected with a manifold (not depicted) that is fixed by a micromanipulator. Bath solution exceeding the internal volume of the cavity is removed with a diaphragm pump through a glass-capillary mounted close to the chamber cavity. Two Ag/AgCl pellets are used for grounding the bath and as reference for the intracellular voltage electrode, respectively. (B) The onset of muscle type nAChR currents was used to assess the speed of solution exchange. Shown are seven superimposed current traces elicited repetitively in 1-min intervals by 5-s 30 μM acetylcholine pulses. A current rise time t10–90% of ∼150 ms was determined for a 10–90% increase of the current amplitude.
	Figure 2. . Desensitization of the P2X1 receptor by incubation at submicromolar ATP concentrations. (A) Shown are current traces elicited by saturating test pulses of 30 μM ATP after preincubation of individual oocytes at 18 nM ATP for the indicated time period. (B) Rate of entry into the desensitized receptor state by preincubation in ATP-containing Mg-ORI. Desensitization was induced using 3 (▪), 10 (•), 18 (▴), 30 (▾), 56 (♦), and 100 nM ATP (+). The lines represent fits of a monoexponential function to the data (6–18 determinations per data point). (C) ATP concentration dependence of steady-state desensitization. Steady-state desensitization levels represented by Iss values were derived from the exponential fits of (B). The curve represents a nonlinear fit of the Hill equation to the data (K1/2 = 3.2 ± 0.1 nM, n = 1.24 ± 0.06; 6–13 determinations per data point). The value at 1 nM ATP was obtained by preincubating the oocytes for 2 h at 1 nM ATP in a Petri dish before transferring them to the superfusion chamber, where the residual current response was elicited by the 30 μM ATP test pulse. (D) ATP concentration dependence of τod, the time-constant of onset of desensitization. τod values are derived from the nonlinear fits shown in (B).
	Figure 3. . Recovery from desensitization. Test responses were elicited by 200 nM ATP applied for a duration of 60 s in intervals ranging from 1 min to 60 min. Between ATP applications oocytes were washed in ATP-free Mg-ORI. One minute after each test response, a control response to 200 nM ATP was elicited which was used to normalize the preceding response of interest. The solid line represents the fit of a monoexponential function to the data yielding the time constant τ = 11.6 ± 1.0 min (N = 4–7).
	Figure 4. . Analysis of P2X1 receptor activation at submicromolar ATP concentrations. (A) ATP dose-response curve for 1 nM to 30 μM ATP (EC50 = 0.7 ± 0.06 μM, n = 1.13 ± 0.08; mean of 11–55 determinations per data point). (B) Scaled current traces elicited by 10–300 nM ATP. ATP was applied until the desensitization process was completed (10 min at 10 nM ATP; 10 s at 300 nM). The gray curves underlying the original current traces (in black) represent fits of the Bateman equation to the data. (C) ATP concentration dependence of activation (▪) and desensitization (▴) time-constants (21–70 determinations per data point). The solid line represents a fit of equation τ = τ0[ATP]−n to the data points (n = 1.75 ± 0.02). In addition, time constants of onset of desensitization (○) taken from Fig. 2 D were replotted to demonstrate that they follow a virtually identical ATP dependence. (D) Areas under current traces elicited by 18–300 nM ATP (11–51 determinations per column). The areas were calculated using the parameters obtained by fitting the Bateman function to the current traces in (A). Numerical integration of the receptor currents yielded virtually identical results (not depicted).
	Figure 5. . Analysis of simulated receptor currents. Receptor currents were simulated for the cyclic three-state model by using the Gepasi Software and analyzed in the same manner as the experimental data. (A) ATP dependence of simulated peak currents in dependence of assumed genuine KD values for receptor activation of 0.03 (▪), 3 (•), 30 (▴), 100 (▾), 300 (♦) and 1.000 nM (◂). A fit of the Hill equation to the simulated data yielded EC50 values of 0.72–1.3 μM for KD values ranging from 0.03 to 1,000 nM, respectively. (B) Relative deviations of the calculated EC50 taken from A from the experimentally determined EC50 value in dependence of the assumed genuine KD values. (C) Steady-state desensitization was calculated using the same set of simulated currents as in (A). A fit of the Hill equation resulted in apparent K1/2 values of 3.4–8.3 nM for KD values of 0.03–1,000 nM, respectively. (D) Relative deviations from the calculated K1/2 values from the experimentally determined K1/2 value in dependence of genuine assumed KD values.

Bartrup, Electrophysiological consequences of ligand binding to the desensitized 5-HT3 receptor in mammalian NG108-15 cells. 1996, Pubmed

Bartrup, Electrophysiological consequences of ligand binding to the desensitized 5-HT3 receptor in mammalian NG108-15 cells. 1996, Pubmed
Bo, High- and low-affinity binding sites for [3H]-alpha, beta-methylene ATP in rat urinary bladder membranes. 1990, Pubmed
Bo, A P2X purinoceptor cDNA conferring a novel pharmacological profile. 1995, Pubmed
Boué-Grabot, A protein kinase C site highly conserved in P2X subunits controls the desensitization kinetics of P2X(2) ATP-gated channels. 2000, Pubmed , Xenbase
Boyd, Kinetics of binding of [3H]acetylcholine to Torpedo postsynaptic membranes: association and dissociation rate constants by rapid mixing and ultrafiltration. 1980, Pubmed
Brake, New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor. 1994, Pubmed , Xenbase
Buell, An antagonist-insensitive P2X receptor expressed in epithelia and brain. 1996, Pubmed
Burnstock, Current status of purinergic signalling in the nervous system. 1999, Pubmed
Changeux, The TiPS lecture. The nicotinic acetylcholine receptor: an allosteric protein prototype of ligand-gated ion channels. 1990, Pubmed
Chen, A P2X purinoceptor expressed by a subset of sensory neurons. 1995, Pubmed , Xenbase
Collo, Cloning OF P2X5 and P2X6 receptors and the distribution and properties of an extended family of ATP-gated ion channels. 1996, Pubmed
Costa, Improved technique for studying ion channels expressed in Xenopus oocytes, including fast superfusion. 1994, Pubmed , Xenbase
Dani, Molecular and cellular aspects of nicotine abuse. 1996, Pubmed
Dilger, Direct measurement of the concentration- and time-dependent open probability of the nicotinic acetylcholine receptor channel. 1990, Pubmed
Ennion, Agonist-stimulated internalisation of the ligand-gated ion channel P2X(1) in rat vas deferens. 2001, Pubmed
Evans, Single channel properties of ATP-gated cation channels (P2X receptors) heterologously expressed in Chinese hamster ovary cells. 1996, Pubmed
Heidmann, Fast kinetic studies on the interaction of a fluorescent agonist with the membrane-bound acetylcholine receptor from Torpedo marmorata. 1979, Pubmed
KATZ, A study of the desensitization produced by acetylcholine at the motor end-plate. 1957, Pubmed
Koshimizu, Contributions of the C-terminal domain to the control of P2X receptor desensitization. 1999, Pubmed
Leff, Potential errors in agonist dissociation constant estimation caused by desensitization. 1986, Pubmed
MacKenzie, Functional and molecular diversity of purinergic ion channel receptors. 1999, Pubmed
Mendes, Biochemistry by numbers: simulation of biochemical pathways with Gepasi 3. 1997, Pubmed
Mendes, GEPASI: a software package for modelling the dynamics, steady states and control of biochemical and other systems. 1993, Pubmed
Methfessel, Patch clamp measurements on Xenopus laevis oocytes: currents through endogenous channels and implanted acetylcholine receptor and sodium channels. 1986, Pubmed , Xenbase
Michel, Distribution and characterisation of [3H]alpha,beta-methylene ATP binding sites in the rat. 1993, Pubmed
Neijt, Kinetics of the membrane current mediated by serotonin 5-HT3 receptors in cultured mouse neuroblastoma cells. 1989, Pubmed
Nicke, P2X1 and P2X3 receptors form stable trimers: a novel structural motif of ligand-gated ion channels. 1998, Pubmed , Xenbase
Nicke, Blue native PAGE as a useful method for the analysis of the assembly of distinct combinations of nicotinic acetylcholine receptor subunits. 1999, Pubmed , Xenbase
Nicke, Monomeric and dimeric byproducts are the principal functional elements of higher order P2X1 concatamers. 2003, Pubmed , Xenbase
Nicke, Evolving view of quaternary structures of ligand-gated ion channels. 1999, Pubmed
North, P2X receptors: a third major class of ligand-gated ion channels. 1996, Pubmed
Rathbone, Trophic effects of purines in neurons and glial cells. 1999, Pubmed
Rettinger, Roles of individual N-glycans for ATP potency and expression of the rat P2X1 receptor. 2000, Pubmed , Xenbase
Schmalzing, Up-regulation of sodium pump activity in Xenopus laevis oocytes by expression of heterologous beta 1 subunits of the sodium pump. 1991, Pubmed , Xenbase
Soto, Cloned ligand-gated channels activated by extracellular ATP (P2X receptors). 1997, Pubmed
Stoop, Contribution of individual subunits to the multimeric P2X(2) receptor: estimates based on methanethiosulfonate block at T336C. 1999, Pubmed , Xenbase
Surprenant, The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). 1996, Pubmed
Valera, A new class of ligand-gated ion channel defined by P2x receptor for extracellular ATP. 1994, Pubmed , Xenbase
Werner, Domains of P2X receptors involved in desensitization. 1996, Pubmed , Xenbase
Witzemann, Primary structure and functional expression of the alpha-, beta-, gamma-, delta- and epsilon-subunits of the acetylcholine receptor from rat muscle. 1990, Pubmed , Xenbase